We are live on ! Find out more
MIRM icon

Mirum Pharmaceuticals
MIRM

72 hedge funds and large institutions have $418M invested in Mirum Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

420% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 5

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

92% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 12

41% more funds holding

Funds holding: 51 → 72 (+21)

17% more capital invested

Capital invested by funds: $357M → $418M (+$60.8M)

7.42% more ownership

Funds ownership: 73.79% → 81.21% (+7.4%)

Holders
72
Holders Change
+21
Holders Change %
+41.18%
% of All Funds
1.27%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
26
Increased
23
Reduced
12
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SCM
Sio Capital Management
New York
+$9.73M
2
DCM
Driehaus Capital Management
Illinois
+$8.54M
3
RSCM
Rock Springs Capital Management
Maryland
+$3.32M
4
BCM
Burrage Capital Management
Massachusetts
+$3.18M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.9M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.07M
2
Two Sigma Investments
Two Sigma Investments
New York
-$743K
3
WVP
Worth Venture Partners
New Jersey
-$677K
4
Goldman Sachs
Goldman Sachs
New York
-$442K
5
Citadel Advisors
Citadel Advisors
Florida
-$225K
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$73.1M – – –
FM
2
Frazier Management
Washington
$62.3M – – –
DM
3
Deerfield Management
New York
$60.2M – – –
NHAS
4
Novo Holdings A/S
Denmark
$42.7M – – –
RVM
5
RiverVest Venture Management
Missouri
$33.5M +$37.8M +1,921,118 New
RSCM
6
Rock Springs Capital Management
Maryland
$26.1M +$3.32M +168,911 +13%
BBA
7
Baker Bros. Advisors
New York
$11.3M +$1.85M +94,304 +17%
Vanguard Group
8
Vanguard Group
Pennsylvania
$11M +$2.9M +147,712 +31%
BlackRock
9
BlackRock
New York
$9.69M +$2.61M +132,920 +31%
DCM
10
Driehaus Capital Management
Illinois
$9.5M +$8.54M +434,341 +395%
SCM
11
Sio Capital Management
New York
$8.64M +$9.73M +494,743 New
SI
12
Sofinnova Investments
California
$7.94M +$2.63M +133,722 +42%
BC
13
Boxer Capital
California
$5.54M – – –
Axa
14
Axa
France
$5.33M +$1.52M +77,496 +34%
Millennium Management
15
Millennium Management
New York
$4.83M +$1.29M +65,796 +31%
ACM
16
AIGH Capital Management
Maryland
$4.79M +$5.4M +274,583 New
BCM
17
Burrage Capital Management
Massachusetts
$2.82M +$3.18M +161,628 New
Fidelity Investments
18
Fidelity Investments
Massachusetts
$2.78M -$1.07M -54,336 -25%
CH
19
CVI Holdings
Delaware
$2.48M +$2.79M +142,035 New
Ensign Peak Advisors
20
Ensign Peak Advisors
Utah
$2.21M +$1.97M +100,000 +379%
MIM
21
Monashee Investment Management
Massachusetts
$2.18M +$2.46M +125,000 New
Geode Capital Management
22
Geode Capital Management
Massachusetts
$1.96M +$44.9K +2,285 +2%
MS
23
Maven Securities
Jersey
$1.82M +$1.97M +100,000 New
Alyeska Investment Group
24
Alyeska Investment Group
Illinois
$1.74M +$972K +49,443 +99%
Northern Trust
25
Northern Trust
Illinois
$1.72M -$52.2K -2,655 -3%
1
2 3 4

MIRM Hedge Fund Activity: Q4 2020 in Review

72 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q4 2020, worth a combined $418M — up 17% from $357M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new MIRM positions and 5 closed out — a net gain of 21 holders — while 23 added to existing stakes and 12 trimmed.

The largest buyer was Sio Capital Management, opening a new position worth an estimated $9.73M. The largest seller was Fidelity Investments, cutting an estimated $1.07M.

  • 72 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q4 2020, up from 51 in Q3 2020.
  • Funds reported $418M of Mirum Pharmaceuticals stock for Q4 2020, up 17% quarter-over-quarter.
  • 26 funds opened new Mirum Pharmaceuticals positions in Q4 2020 and 5 closed out, a net change of +21 holders.
  • The largest Mirum Pharmaceuticals buyer in Q4 2020 was Sio Capital Management, an estimated $9.73M added.
  • The largest Mirum Pharmaceuticals seller in Q4 2020 was Fidelity Investments, an estimated $1.07M sold.

Based on aggregated 13F filings for Q4 2020.